In 2008, a genome-wide sequencing study identified somatic mutations in IDH1 in 18 (12%) of 149 patients with GBM [12] and it was subsequently found that GBMs without IDH1 mutations often have mutations affecting IDH2[13]. Here, IDH1 is linked to glioblastoma.